0001171843-22-004042.txt : 20220531 0001171843-22-004042.hdr.sgml : 20220531 20220531171341 ACCESSION NUMBER: 0001171843-22-004042 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220531 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220531 DATE AS OF CHANGE: 20220531 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aptose Biosciences Inc. CENTRAL INDEX KEY: 0000882361 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-32001 FILM NUMBER: 22984606 BUSINESS ADDRESS: STREET 1: 251 CONSUMERS ROAD STREET 2: SUITE 1105 CITY: TORONTO STATE: A6 ZIP: M2J 4R3 BUSINESS PHONE: 647-479-9828 MAIL ADDRESS: STREET 1: 251 CONSUMERS ROAD STREET 2: SUITE 1105 CITY: TORONTO STATE: A6 ZIP: M2J 4R3 FORMER COMPANY: FORMER CONFORMED NAME: Aptose Biosciences Inc., (formerly LORUS THERAPEUTICS INC.) DATE OF NAME CHANGE: 20140905 FORMER COMPANY: FORMER CONFORMED NAME: LORUS THERAPEUTICS INC DATE OF NAME CHANGE: 19990308 FORMER COMPANY: FORMER CONFORMED NAME: IMUTEC PHARMA INC DATE OF NAME CHANGE: 19970113 8-K 1 f8k_053122.htm FORM 8-K Form 8-K
0000882361 False 0000882361 2022-05-31 2022-05-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

FORM 8-K

_________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  May 31, 2022

_______________________________

Aptose Biosciences Inc.

(Exact name of registrant as specified in its charter)

_______________________________

Canada001-3200198-1136802
(State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification No.)

251 Consumers Road, Suite 1105

Toronto, Ontario Canada M2J 4R3

(Address of Principal Executive Offices) (Zip Code)

(647) 479-9828

(Registrant's telephone number, including area code)

 

(Former name or former address, if changed since last report)

_______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Shares, no par valueAPTONasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 
 
Item 5.07. Submission of Matters to a Vote of Security Holders.

On May 31, 2022, Aptose Biosciences Inc., or the “Corporation”, held its Annual General Meeting of Shareholders.  At the meeting, shareholders voted in favor of all items of business, as indicated below:

Proposal No. 1—Election of Directors

The Corporation’s shareholders voted to elect the following persons to the board of directors of the Corporation, each to serve until the 2022 Annual General Meeting:

Nominee Votes For% Votes For Votes Withheld% Votes WithheldBroker Non-Votes
Ms. Carol G. Ashe 17,610,84797.26 495,4322.7431,202,256
Dr. Denis Burger 17,742,80497.99 363,4752.0131,202,256
Dr. Erich Platzer 17,727,28997.91 378,9902.0931,202,256
Dr. William G. Rice 17,620,55997.32 485,7202.6831,202,256
Dr. Mark D. Vincent 16,878,01993.22 1,228,2606.7831,202,256
Mr. Warren Whitehead 17,729,50197.92 376,7782.0831,202,256

Proposal No. 2—Appointment of Independent Registered Public Accounting Firm

The Corporation’s shareholders voted to approve the appointment of KPMG LLP as the independent registered public accounting firm of the Corporation until the next annual shareholders’ meeting or until a successor is named.

Votes For% Votes ForVote Against% Votes AgainstAbstainBroker Non-Votes
47,107,99295.542,038,6234.13161,9200

Proposal No. 3—Resolution on amendment of the 2021 Stock Incentive Plan

The Corporation’s shareholders passed an ordinary resolution approving an amendment to the Corporation’s 2021 stock incentive plan to increase the number of shares available thereunder by 3,000,000.

Votes For% Votes ForVote Against% Votes AgainstAbstainBroker Non-Votes
16,600,48491.681,422,3307.8683,46431,202,257

Proposal No. 4—Resolution on Compensation of Corporations Named Executive Officers

The Corporation’s shareholders passed an advisory (non-binding) resolution to approve the compensation of the Corporation’s named executive officers.

Votes For% Votes ForVote Against% Votes AgainstAbstainBroker Non-Votes
16,902,57493.351,031,9785.70171,72731,202,256

 

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit 99.1. Press release, dated May 31, 2022

Exhibit 104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 
 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 Aptose Biosciences Inc.
   
  
Date: May 31, 2022By: /s/ William G. Rice, Ph.D.        
  William G. Rice, Ph.D.
  Chairman, President and Chief Operating Officer
  

 

 EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling

EXHIBIT 99.1

Aptose Biosciences Announces Results of Annual Meeting of Shareholders

SAN DIEGO and TORONTO, May 31, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, today announced the voting results from the Company’s annual and special meeting of shareholders held today, May 31, 2022 (the “Meeting”). A total of 53.46% of the common shares of the Company entitled to be voted were represented by shareholders present or represented by proxy at the Meeting.

The Company is pleased to announce that all of the nominees listed in the proxy statement dated April 19, 2022 were elected as Directors. The results of the vote are detailed below:

NomineeVotes For% VotesVotes% Votes 
  ForWithheldWithheld 
Ms. Carol G. Ashe17,610,84797.26495,4322.74 
Dr. Denis Burger17,742,80497.99363,4752.01 
Dr. Erich Platzer17,727,28997.91378,9902.09 
Dr. William G. Rice17,620,55997.32485,7202.68 
Dr. Mark D. Vincent16,878,01993.221,228,2606.78 
Mr. Warren Whitehead17,729,50197.92376,7782.08 

Aptose shareholders also voted in favor of the following matters:

  • the re-appointment of KPMG LLP as the independent registered public accounting firm of the Company
  • a resolution to approve an amendment to the Aptose’s 2021 Stock Incentive Plan to increase the number of shares available thereunder by 3,000,000 shares
  • a non-binding resolution to approve of the compensation paid to Aptose’s named executive officers

Please refer to the Company’s proxy statement available on SEDAR at www.sedar.com or EDGAR https://www.sec.gov/edgar.shtml for more details on the matters covered at the Meeting. Final voting results on all matters voted on at the Meeting will also be filed on SEDAR and EDGAR.

About Aptose

Aptose Biosciences is a clinical-stage biotechnology company committed to developing precision medicines addressing unmet medical needs in oncology, with an initial focus on hematology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities. The Company has two clinical-stage oral kinase inhibitors under development for hematologic malignancies: HM43239, an oral, myeloid kinome inhibitor in an international Phase 1/2 trial in patients with relapsed or refractory acute myeloid leukemia (AML); and luxeptinib, an oral, dual lymphoid and myeloid kinome inhibitor in a Phase 1 a/b trial in patients with relapsed or refractory B cell malignancies who have failed or are intolerant to standard therapies, and in a separate Phase 1 a/b trial in patients with relapsed or refractory AML or high risk myelodysplastic syndrome (MDS). For more information, please visit www.aptose.com.

For further information, please contact:
  
Aptose Biosciences Inc.
Susan Pietropaolo
Investor Relations
201-923-2049
spietropaolo@aptose.com		LifeSci Advisors, LLC
Dan Ferry, Managing Director
617-535-7746
Daniel@LifeSciAdvisors.com

 EX-101.SCH 3 gnw-20190101.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 gnw-20190101_def.xml XBRL DEFINITION FILE EX-101.LAB 5 gnw-20190101_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 gnw-20190101_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover
May 31, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 31, 2022
Entity File Number 001-32001
Entity Registrant Name Aptose Biosciences Inc.
Entity Central Index Key 0000882361
Entity Tax Identification Number 98-1136802
Entity Incorporation, State or Country Code Z4
Entity Address, Address Line One 251 Consumers Road, Suite 1105
Entity Address, City or Town Toronto
Entity Address, State or Province ON
Entity Address, Postal Zip Code M2J 4R3
City Area Code 647
Local Phone Number 479-9828
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Shares, no par value
Trading Symbol APTO
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 8 f8k_053122_htm.xml IDEA: XBRL DOCUMENT 0000882361 2022-05-31 2022-05-31 iso4217:USD shares iso4217:USD shares 0000882361 false 8-K 2022-05-31 Aptose Biosciences Inc. Z4 001-32001 98-1136802 251 Consumers Road, Suite 1105 Toronto ON M2J 4R3 647 479-9828 false false false false Common Shares, no par value APTO NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 22 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://globenewswire.com/role/Cover Cover Cover 1 false false All Reports Book All Reports f8k_053122.htm exh_991.htm gnw-20190101.xsd gnw-20190101_def.xml gnw-20190101_lab.xml gnw-20190101_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f8k_053122.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "local": [ "gnw-20190101_def.xml" ] }, "inline": { "local": [ "f8k_053122.htm" ] }, "labelLink": { "local": [ "gnw-20190101_lab.xml" ] }, "presentationLink": { "local": [ "gnw-20190101_pre.xml" ] }, "schema": { "local": [ "gnw-20190101.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "gnw", "nsuri": "http://globenewswire.com/20190101", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "f8k_053122.htm", "contextRef": "Form8K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://globenewswire.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "f8k_053122.htm", "contextRef": "Form8K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r9", "r11", "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://globenewswire.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r10": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r11": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r12": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r13": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r14": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r15": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r16": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r17": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r18": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r9": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" } }, "version": "2.1" } ZIP 15 0001171843-22-004042-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001171843-22-004042-xbrl.zip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